← Back to Search

Behavioral Intervention

SMART-IBD App for Inflammatory Bowel Disease

N/A

Waitlist Available

Research Sponsored by Children's Hospital Medical Center, Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial tests if an app helps teens with IBD take their medicine and learn self-care skills. It will compare 15 teens using the app to 15 teens in a control group.

Who is the study for?

This trial is for adolescents aged 13-17 with Crohn's disease, ulcerative colitis, or indeterminate colitis. Participants must have internet access and a smartphone, be fluent in English, and be on at least one IBD medication. Those with developmental disorders or serious mental illness are excluded.Check my eligibility

What is being tested?

The SMART-IBD app is being tested to see if it helps young people manage their IBD better by reminding them to take their meds and teaching them about their condition. The study compares an app-using group against a control group over three months.See study design

What are the potential side effects?

Since this trial involves the use of an educational smartphone app rather than medication, there are no direct medical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medication adherence

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SMART-IBDExperimental Treatment1 Intervention

The SMART-IBD app consists of educational content, medication reminders, and weekly app engagement challenges. App users will participate in weekly challenges that focus on topics such as adherence, sleep, and diary usage. Participants in this arm will complete one month of run-in diaries, one month of diaries during intervention, and one month of diaries post-intervention.

Group II: Attention ControlActive Control1 Intervention

Participants in this arm will not receive any intervention content. Participants in this arm will complete one month of run-in diaries, one month of diaries during intervention and one month of diaries post-intervention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SMART-IBD

2022

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor

815 Previous Clinical Trials

6,531,546 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals aged 50 or above able to participate in this scientific investigation?

"According to the parameters of this study, adolescents aged 13-17 are eligible for participation."

Answered by AI

Is there a way I can participate in this medical research?

"To gain admittance to the trial, applicants must suffer from inflammatory bowel disease and be in between the ages of 13 and 17. Approximately 30 participants will be taken on by this study."

Answered by AI

Does this investigation still accept new participants?

"Confirmed, data hosted on clinicaltrials.gov confirms that this research effort is actively enrolling individuals as of today; the trial was first announced on December 14th 2022 and last updated on September 1st 2023. 30 participants are needed from a single recruitment site."

Answered by AI

How many participants have been recruited to participate in this experiment?

"Affirmative. The information hosted on clinicaltrials.gov alludes to the fact that this medical trial is presently recruiting participants. It was initially launched on December 14th 2022 and most recently amended on September 1st 2023, with a requirement for 30 individuals from one site to take part in the experiment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SMART-IBD App Trial

2022. "SMART-IBD App Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06023667.